Stocks and InvestingStocks and Investing
Tue, April 17, 2018
Mon, April 16, 2018
Fri, April 13, 2018
Thu, April 12, 2018
Wed, April 11, 2018
Tue, April 10, 2018
Mon, April 9, 2018
Fri, April 6, 2018
Thu, April 5, 2018

Geoff Meacham Maintained (AMGN) at Hold with Decreased Target to $180 on, Apr 5th, 2018


Published on 2024-10-26 04:17:05 - WOPRAI, Geoff Meacham
  Print publication without navigation


Geoff Meacham of Barclays, Maintained "Amgen Inc." (AMGN) at Hold with Decreased Target from $190 to $180 on, Apr 5th, 2018.

Geoff has made no other calls on AMGN in the last 4 months.



There are 7 other peers that have a rating on AMGN. Out of the 7 peers that are also analyzing AMGN, 4 agree with Geoff's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Steve Chesney of "Atlantic Equities" Downgraded from Buy to Hold on, Monday, February 5th, 2018
  • Ian Somaiya of "BMO Capital" Maintained at Hold with Increased Target to $202 on, Friday, February 2nd, 2018
  • Alethia Young of "Credit Suisse" Maintained at Hold with Increased Target to $194 on, Friday, February 2nd, 2018
  • Cory Kasimov of "JP Morgan" Maintained at Hold with Increased Target to $189 on, Wednesday, January 24th, 2018


These are the ratings of the 3 analyists that currently disagree with Geoff


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $196 on, Friday, February 2nd, 2018
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $190 on, Friday, February 2nd, 2018
  • David Toung of "Argus Research" Upgraded from Hold to Strong Buy and Held Target at $220 on, Tuesday, January 23rd, 2018